Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003988326 | SCV004804069 | pathogenic | Autosomal recessive nonsyndromic hearing loss 3 | 2024-01-31 | criteria provided, single submitter | clinical testing | Variant summary: MYO15A c.439G>T (p.Glu147X) results in a premature termination codon, predicted to cause absence of the protein due to nonsense mediated decay, which is a commonly known mechanism for disease. The variant was absent in 240628 control chromosomes. To our knowledge, no occurrence of c.439G>T in individuals affected with Autosomal Recessive Nonsyndromic Hearing Loss 3 and no experimental evidence demonstrating its impact on protein function have been reported. No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined above, the variant was classified as pathogenic. |